Viral DNA Testing Is Cost-Effective for Cervical Cancer Screening

ScienceDaily (Feb. 27, 2008) — Adjustment of cervical cancer screening protocols as a woman ages may be cost-effective, regardless of whether she has been vaccinated against the human papillomavirus (HPV) that causes cervical cancer.

MORE ON THIS TOPIC